• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症生物学中的 miRNA 异质性水平。

Levels of MicroRNA Heterogeneity in Cancer Biology.

机构信息

Department for Radiobiology and Molecular Genetics, Vinca Institute of Nuclear Sciences, University of Belgrade, Mike Alasa 12-14, Belgrade, 11000, Serbia.

Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, 11000, Serbia.

出版信息

Mol Diagn Ther. 2017 Oct;21(5):511-523. doi: 10.1007/s40291-017-0285-9.

DOI:10.1007/s40291-017-0285-9
PMID:28620889
Abstract

MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression, involved in the silencing of messenger RNA (mRNA) translation. The importance of miRNA signatures in disease screening, prognosis, and progression of different tumor types and subtypes is increasing. miRNA expression levels change depending on numerous factors. In this review, we are describing the circumstances under which miRNA levels can change, these are named 'levels' of heterogeneity of miRNAs. miRNAs can have oncogenic, tumor suppressive, or both roles depending on tumor type and target mRNA whose translation they silence. The expression levels of a single miRNA may vary across different cancer types and subtypes, indicating that a miRNA signature may be tissue specific. miRNA levels of expression also vary during disease formation and propagation, indicating the presence of a time profile for their expression. The complexity of the miRNA-mRNA interference network mirrors different genetic and epigenetic changes that influence miRNA and mRNA availability to each other, and hence, their binding ability. The potential role of miRNAs as biomarkers is two-fold; first, for monitoring of the phases of cancer pathogenesis, and second, to characterize the particular type/subtype of cancer. It is important that a particular miRNA should be characterized by examining as many types and subtypes of cancers as are available, as well as being extracted from different types of samples, in order to obtain a complete picture of its behavior and importance in the disease pathology.

摘要

微小 RNA(miRNAs)是基因表达的转录后调控因子,参与信使 RNA(mRNA)翻译的沉默。miRNA 特征在不同肿瘤类型和亚型的疾病筛查、预后和进展中的重要性日益增加。miRNA 的表达水平取决于许多因素。在这篇综述中,我们描述了 miRNA 水平可以改变的情况,这些情况被称为 miRNA 的“水平”异质性。miRNA 可以具有致癌或肿瘤抑制作用,也可以根据肿瘤类型和它们沉默的翻译靶 mRNA 而具有双重作用。单个 miRNA 的表达水平可能在不同的癌症类型和亚型中有所不同,表明 miRNA 特征可能具有组织特异性。miRNA 的表达水平也在疾病形成和传播过程中发生变化,表明其表达存在时间谱。miRNA-mRNA 干扰网络的复杂性反映了影响 miRNA 和 mRNA 相互可用性的不同遗传和表观遗传变化,因此也反映了它们的结合能力。miRNA 作为生物标志物的潜在作用有两个方面;首先,用于监测癌症发病机制的各个阶段,其次,用于表征特定类型/亚型的癌症。重要的是,应该通过检查尽可能多的癌症类型和亚型,以及从不同类型的样本中提取,来对特定的 miRNA 进行特征描述,以便获得其在疾病病理学中的行为和重要性的完整图景。

相似文献

1
Levels of MicroRNA Heterogeneity in Cancer Biology.癌症生物学中的 miRNA 异质性水平。
Mol Diagn Ther. 2017 Oct;21(5):511-523. doi: 10.1007/s40291-017-0285-9.
2
Identifying significant microRNA-mRNA pairs associated with breast cancer subtypes.识别与乳腺癌亚型相关的重要微小RNA-信使核糖核酸对。
Mol Biol Rep. 2016 Jul;43(7):591-9. doi: 10.1007/s11033-016-4021-z. Epub 2016 May 31.
3
MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.微小RNA表达与基因调控驱动PyMT小鼠乳腺癌的进展和转移。
Breast Cancer Res. 2016 Jul 22;18(1):75. doi: 10.1186/s13058-016-0735-z.
4
Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.甲状腺癌公共数据集的综合分析揭示了转录后调控通过靶向免疫系统介质对肿瘤进展的作用。
PLoS One. 2015 Nov 4;10(11):e0141726. doi: 10.1371/journal.pone.0141726. eCollection 2015.
5
Prioritizing breast cancer subtype related miRNAs using miRNA-mRNA dysregulated relationships extracted from their dual expression profiling.利用从双重表达谱中提取的 miRNA-mRNA 失调关系,优先考虑乳腺癌亚型相关 miRNA。
J Theor Biol. 2013 Aug 21;331:1-11. doi: 10.1016/j.jtbi.2013.04.008. Epub 2013 Apr 22.
6
Regulatory microRNA networks: complex patterns of target pathways for disease-related and housekeeping microRNAs.调控性微小RNA网络:疾病相关微小RNA和管家微小RNA的靶标通路复杂模式
Genomics Proteomics Bioinformatics. 2015 Jun;13(3):159-68. doi: 10.1016/j.gpb.2015.02.004. Epub 2015 Jul 11.
7
Genome-wide analysis of microRNA and mRNA expression signatures in cancer.癌症中微小RNA和信使核糖核酸表达特征的全基因组分析。
Acta Pharmacol Sin. 2015 Oct;36(10):1200-11. doi: 10.1038/aps.2015.67. Epub 2015 Aug 24.
8
Identification of Disease-miRNA Networks Across Different Cancer Types Using SWIM.使用SWIM识别不同癌症类型中的疾病- miRNA网络。
Methods Mol Biol. 2019;1970:169-181. doi: 10.1007/978-1-4939-9207-2_10.
9
Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.作为肺癌早期诊断潜在生物标志物的微小RNA差异表达谱
Oncol Rep. 2017 Jun;37(6):3543-3553. doi: 10.3892/or.2017.5612. Epub 2017 Apr 28.
10
MiRNA-BD: an evidence-based bioinformatics model and software tool for microRNA biomarker discovery.miRNA 结合数据库:一种基于证据的生物信息学模型和软件工具,用于发现 microRNA 生物标志物。
RNA Biol. 2018;15(8):1093-1105. doi: 10.1080/15476286.2018.1502590. Epub 2018 Sep 17.

引用本文的文献

1
Functional Characterization of miR-216a-5p and miR-125a-5p on Pancreatic Cancer Stem Cells.miR-216a-5p和miR-125a-5p对胰腺癌干细胞的功能表征
Int J Mol Sci. 2025 Mar 21;26(7):2830. doi: 10.3390/ijms26072830.
2
mir-188-5p emerges as an oncomir to promote chronic myeloid leukemia via upregulation of BUB3 and SUMO2.微小RNA-188-5p作为一种致癌微小RNA,通过上调BUB3和SUMO2来促进慢性髓性白血病。
Mol Biol Rep. 2025 Feb 28;52(1):269. doi: 10.1007/s11033-025-10359-9.
3
A sandwich-type electrochemiluminescence biosensor based on Ni(HAB)/Au@ZnNiAl-LDH/Ru@MIL-53(Al)-NH for ultra-sensitive detection of microRNA-155.

本文引用的文献

1
dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers.dbDEMC 2.0:人类癌症中差异表达的微小RNA的更新数据库。
Nucleic Acids Res. 2017 Jan 4;45(D1):D812-D818. doi: 10.1093/nar/gkw1079. Epub 2016 Nov 28.
2
Genetic variation in the miR-4273-5p target site is associated with a risk of colorectal cancer.miR-4273-5p靶位点的基因变异与结直肠癌风险相关。
Onco Targets Ther. 2016 Nov 7;9:6885-6895. doi: 10.2147/OTT.S108787. eCollection 2016.
3
Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels.
一种基于Ni(HAB)/Au@ZnNiAl-LDH/Ru@MIL-53(Al)-NH的三明治型电化学发光生物传感器,用于超灵敏检测微小RNA-155。
Mikrochim Acta. 2024 Dec 22;192(1):26. doi: 10.1007/s00604-024-06870-8.
4
Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell models.揭示胰腺导管腺癌患者和癌细胞模型中的 microRNA 图谱。
BMC Cancer. 2024 Oct 24;24(1):1308. doi: 10.1186/s12885-024-13007-w.
5
Non-Coding RNAs and Innate Immune Responses in Cancer.癌症中的非编码RNA与先天免疫反应
Biomedicines. 2024 Sep 11;12(9):2072. doi: 10.3390/biomedicines12092072.
6
Cancer-specific risk prediction with a serum microRNA signature.基于血清 microRNA 特征的癌症特异性风险预测。
Cancer Sci. 2024 Jun;115(6):2049-2058. doi: 10.1111/cas.16135. Epub 2024 Mar 24.
7
Decreased expression of miR-23b is associated with poor survival of endometrial cancer patients.miR-23b 表达降低与子宫内膜癌患者生存不良有关。
Sci Rep. 2022 Nov 5;12(1):18824. doi: 10.1038/s41598-022-22306-w.
8
Assessment of a Serum Microrna Risk Score for Colorectal Cancer among Participants of Screening Colonoscopy at Various Stages of Colorectal Carcinogenesis.基于结直肠癌发生发展不同阶段行筛查性结肠镜检查者的血清 microRNA 风险评分对结直肠癌的评估。
Cells. 2022 Aug 8;11(15):2462. doi: 10.3390/cells11152462.
9
A microRNA panel compared to environmental and polygenic scores for colorectal cancer risk prediction.微 RNA 面板与环境和多基因评分在结直肠癌风险预测中的比较。
Nat Commun. 2021 Aug 10;12(1):4811. doi: 10.1038/s41467-021-25067-8.
10
MicroRNA as a Novel Biomarker in the Diagnosis of Head and Neck Cancer.微小 RNA 作为头颈部癌症诊断的新型生物标志物。
Biomolecules. 2021 Jun 5;11(6):844. doi: 10.3390/biom11060844.
乳腺浸润性癌和原位癌中miR-221/222水平的变化:与雌激素受体及TIMP3表达水平相关性的差异
Mol Diagn Ther. 2016 Dec;20(6):603-615. doi: 10.1007/s40291-016-0230-3.
4
Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).靶向致癌 miRNA 并模拟肿瘤抑制 miRNA:肿瘤 miRNA 治疗策略开发的新趋势(综述)。
Int J Oncol. 2016 Jul;49(1):5-32. doi: 10.3892/ijo.2016.3503. Epub 2016 May 4.
5
MicroRNA Expression Profiles in Papillary Thyroid Carcinoma, Benign Thyroid Nodules and Healthy Controls.甲状腺乳头状癌、甲状腺良性结节及健康对照中的微小RNA表达谱
J Cancer. 2016 Apr 26;7(7):803-9. doi: 10.7150/jca.13898. eCollection 2016.
6
Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer.结直肠癌中微小RNA-21、微小RNA-34a和微小RNA-126的血清学表达不足
Acta Cir Bras. 2016;31 Suppl 1:13-8. doi: 10.1590/S0102-86502016001300004.
7
Co‑inhibition of miRNA‑21 and miRNA‑221 induces apoptosis by enhancing the p53‑mediated expression of pro‑apoptotic miRNAs in laryngeal squamous cell carcinoma.miRNA-21和miRNA-221的共同抑制通过增强p53介导的促凋亡miRNA在喉鳞状细胞癌中的表达来诱导细胞凋亡。
Mol Med Rep. 2016 May;13(5):4315-20. doi: 10.3892/mmr.2016.5048. Epub 2016 Mar 28.
8
MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.高级别前列腺上皮内瘤变和前列腺癌中的微小RNA改变及潜在靶基因:STAT3和ZEB1在前列腺癌发生过程中上调。
Prostate. 2016 Jul;76(10):937-47. doi: 10.1002/pros.23183. Epub 2016 Mar 28.
9
Re-evaluation of the roles of DROSHA, Export in 5, and DICER in microRNA biogenesis.对 Drosha、5' 端输出因子及 Dicer 在微小RNA生物合成中作用的重新评估。
Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):E1881-9. doi: 10.1073/pnas.1602532113. Epub 2016 Mar 14.
10
Length variants of the ABCB1 3'-UTR and loss of miRNA binding sites: possible consequences in regulation and pharmacotherapy resistance.ABCB1 3'-非翻译区的长度变异与微小RNA结合位点的缺失:对调控及药物治疗耐药性可能产生的影响
Pharmacogenomics. 2016 Mar;17(4):327-40. doi: 10.2217/pgs.15.175. Epub 2016 Feb 19.